Value proposition

Sterling Pharma Solutions is a leading provider of API services to the pharmaceutical industry.

Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries.

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services.

Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; a Partnership Development and Manufacturing Organisation (PDMO®).

Sterling has six facilities across the UK, USA and Europe, employing 1,350+ people, including in Cramlington and Newcastle, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US.

Find out more: www.sterlingpharmasolutions.com/sterling-facilities

Chiral compounds, Custom manufacturing, Fluorination, Cryogenic, Hazardous chemistry, Continuous processing and scale-up, Controlled release, API development, API manufacturing, Drug substance, Drug substance development, Drug substance manufacturing, controlled substance APIs, Potent APIs, hazardous evaluation, material science, solid state chemistry , milling, micronisation, micronization, ADCs, Antibody Drug Conjugation, Bioconjugation, HPAPI, High Potency API, and Highly Potent API